Immunotherapy for Advanced Non–Small Cell Lung Cancer: A Decade of Progress
Author:
Affiliation:
1. Department of Oncologic Sciences, Morsani College of Medicine, University of South Florida,Tampa, FL
2. Department of Thoracic Oncology, Moffitt Cancer Center and Research Institute, Tampa, FL
Abstract
Publisher
American Society of Clinical Oncology (ASCO)
Subject
General Medicine
Link
https://ascopubs.org/doi/pdfdirect/10.1200/EDBK_321483
Reference37 articles.
1. Cancer Statistics, 2021
2. One Hundred Years of Lung Cancer
3. Systemic Therapy for Locally Advanced and Metastatic Non–Small Cell Lung Cancer
4. New insights into cancer immunoediting and its three component phases—elimination, equilibrium and escape
5. PD-1 and Its Ligands in Tolerance and Immunity
Cited by 74 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Radiation and resolve: unlocking the synergistic potential of radioimmunotherapy in advanced lung cancer management;Immunotherapy;2024-02
2. Dynamic immune signatures of patients with advanced non–small-cell lung cancer for infection prediction after immunotherapy;Frontiers in Immunology;2024-01-26
3. Real‐world survival outcomes of immunotherapy for advanced non‐small cell lung cancer: A single‐center retrospective review;Thoracic Cancer;2024-01-18
4. The Cross-Scale Association between Pathomics and Radiomics Features in Immunotherapy-Treated NSCLC Patients: A Preliminary Study;Cancers;2024-01-13
5. Biological insights from plasma proteomics of non-small cell lung cancer patients treated with immunotherapy;2024-01-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3